BORTEZOMIB, LIPOSOMAL DOXORUBICIN AND DEXAMETHASONE REGIMEN FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND INTRODUCTION OF SERUM FREE LIGHT CHAINS (SFLC) IN RESPONSE MONITORING: PRELIMINARY DATA

被引：0
|
作者：
Pisani, F.
Cordone, I. [1 ]
Dessanti, M. L. [2 ]
Cigliana, G. [1 ]
Frollano, B. [1 ]
Masi, S. [1 ]
Mengarelli, A. [2 ]
Spadea, A. [2 ]
D'Andrea, M. [2 ]
Petti, M. C. [2 ]
机构：
[1] Ist Nazl Tumori Regina Elena, SC Patol Clin, Rome, Italy
[2] Ist Nazl Tumori Regina Elena, SC Ematol, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1106
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [1] Bortezomib, liposomal doxorubicin and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma
    Falcone, A.
    Sanpaolo, G.
    Bodenizza, C.
    Carella, A. M.
    Dell'Olio, M.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Scalzulli, F.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 147 - 148
  • [2] A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma
    Gabriel N. Waterman
    Ori Yellin
    Regina A. Swift
    Russell Mapes
    Benjamin Eades
    Emily Ackerman
    James R. Berenson
    Annals of Hematology, 2011, 90 : 193 - 200
  • [3] A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma
    Waterman, Gabriel N.
    Yellin, Ori
    Swift, Regina A.
    Mapes, Russell
    Eades, Benjamin
    Ackerman, Emily
    Berenson, James R.
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 193 - 200
  • [4] Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma
    Ning, Yang-Min
    He, Kun
    Dagher, Ramz
    Sridhara, Rajeshwari
    Farrell, Ann T.
    Justice, Robert
    Pazdur, Richard
    ONCOLOGY-NEW YORK, 2007, 21 (12): : 1503 - 1508
  • [5] Pegylated liposomal doxorubicin and bortezomib in relapsed/refractory multiple myeloma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 453 - 455
  • [6] A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma
    Berenson, J. R.
    Yellin, O.
    Kazamel, T.
    Hilger, J. D.
    Chen, C-S
    Cartmell, A.
    Woliver, T.
    Flam, M.
    Bravin, E.
    Nassir, Y.
    Vescio, R.
    Swift, R. A.
    LEUKEMIA, 2012, 26 (07) : 1675 - 1680
  • [7] A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma
    J R Berenson
    O Yellin
    T Kazamel
    J D Hilger
    C-S Chen
    A Cartmell
    T Woliver
    M Flam
    E Bravin
    Y Nassir
    R Vescio
    R A Swift
    Leukemia, 2012, 26 : 1675 - 1680
  • [8] Association of bortezomib, doxorubicin and dexamethasone (PAD) in relapsed and refractory multiple myeloma patients
    Palumbo, A.
    Gay, F.
    Falcone, A.
    Pescosta, N.
    Callea, V
    Caravita, T.
    Morabito, F.
    Falco, P.
    Larocca, A.
    Avonto, I
    Musto, P.
    Cascavilla, N.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 31 - 32
  • [9] Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients
    Romano, Alessandra
    Chiarenza, Annalisa
    Conticello, Concetta
    Cavalli, Maide
    Vetro, Calogero
    Di Raimondo, Cosimo
    Cunsolo, Rosario
    Palumbo, Giuseppe Alberto
    Di Raimondo, Francesco
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (03) : 207 - 213
  • [10] Relapsed or Refractory Multiple Myeloma: Prospective Study with Bortezomib, Non-Pegylated Liposomal Doxorubicin and Dexamethason (PAD Regimen)
    Falcone, Antonietta Pia
    Sanpaolo, Grazia
    Rossi, Giovanni
    Bodenizza, Carlo
    Carella, Angelo Michele
    Dell' Olio, Matte
    Greco, Michele Mario
    La Sala, Antonio
    Mantuano, Saverio
    Melillo, Lorella
    Merla, Emanuela
    Nobile, Michele
    Scalzulli, Potito R.
    Capalbo, Silvana
    Cascavilla, Nicola
    BLOOD, 2012, 120 (21)
12345